Catheter Precision (VTAK) to Release Earnings on Friday

Catheter Precision (NYSEAMERICAN:VTAK) is projected to announce its earnings results before the market opens on Friday, April 4th. Analysts expect the company to announce earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Stock Down 2.0 %

Catheter Precision stock opened at $0.34 on Thursday. Catheter Precision has a 12-month low of $0.30 and a 12-month high of $8.40. The company has a current ratio of 0.66, a quick ratio of 0.65 and a debt-to-equity ratio of 0.12. The business’s fifty day moving average price is $0.38.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.